BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 16136463)

  • 1. Lung remodeling in pulmonary tuberculosis.
    Dheda K; Booth H; Huggett JF; Johnson MA; Zumla A; Rook GA
    J Infect Dis; 2005 Oct; 192(7):1201-9. PubMed ID: 16136463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The formation of the granuloma in tuberculosis infection.
    Orme IM; Basaraba RJ
    Semin Immunol; 2014 Dec; 26(6):601-9. PubMed ID: 25453231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mycobacterium tuberculosis and its host].
    Vincent V; Marchal G
    Rev Prat; 2002 Dec; 52(19):2111-4. PubMed ID: 12602231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nude rat (F344/N-rnu) tuberculosis.
    Sugawara I; Yamada H; Mizuno S
    Cell Microbiol; 2006 Apr; 8(4):661-7. PubMed ID: 16548891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung granulomas from Mycobacterium tuberculosis/HIV-1 co-infected patients display decreased in situ TNF production.
    de Noronha AL; Báfica A; Nogueira L; Barral A; Barral-Netto M
    Pathol Res Pract; 2008; 204(3):155-61. PubMed ID: 18096327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma-dependent mechanisms of mycobacteria-induced pulmonary immunopathology: the role of angiostasis and CXCR3-targeted chemokines for granuloma necrosis.
    Aly S; Laskay T; Mages J; Malzan A; Lang R; Ehlers S
    J Pathol; 2007 Jul; 212(3):295-305. PubMed ID: 17534845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of M. tuberculosis Infection.
    Orme I; Gonzalez-Juarrero M
    Curr Protoc Microbiol; 2007 Nov; Chapter 10():Unit 10A.5. PubMed ID: 18770606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the function of granulomas in human tuberculosis.
    Ulrichs T; Kaufmann SH
    J Pathol; 2006 Jan; 208(2):261-9. PubMed ID: 16362982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection.
    Bhatt K; Uzelac A; Mathur S; McBride A; Potian J; Salgame P
    J Immunol; 2009 Mar; 182(6):3793-800. PubMed ID: 19265158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progressing of pulmonary tuberculosis and the frequency of histological identification of Mycobacterium tuberculosis in caseation].
    Tkachuk VI
    Probl Tuberk; 1971; 49(7):71-6. PubMed ID: 5004350
    [No Abstract]   [Full Text] [Related]  

  • 11. [Unique manifestations of the pathomorphosis of pulmonary tuberculosis].
    Braude VI
    Arkh Patol; 1982; 44(1):29-34. PubMed ID: 7065920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in pulmonary fibrosis: 6--Problematic granulomatous lung disease.
    Myers JL; Tazelaar HD
    Thorax; 2008 Jan; 63(1):78-84. PubMed ID: 18156572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathological studies of tuberculosis and their prospect].
    Iwai K
    Kekkaku; 1982 Oct; 57(10):507-12. PubMed ID: 6819378
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathomorphological characteristics of tuberculosis in relation to the variability of the causative agent].
    Puzik VI; Zemskova ZS; Dorozhkova IR; Nurusheva AM
    Probl Tuberk; 1981 Jul; (7):50-4. PubMed ID: 6792629
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis.
    Dorhoi A; Kaufmann SH
    Semin Immunopathol; 2016 Mar; 38(2):153-66. PubMed ID: 26438324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of L-form mycobacteria in the development of pulmonary tuberculosis].
    Snitinskaia OS; Sibirnaia RI; Beliakova OI
    Vrach Delo; 1990 Mar; (3):38-40. PubMed ID: 2114701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis.
    Thachil J
    Med Hypotheses; 2009 Mar; 72(3):291-3. PubMed ID: 19036527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycobacterium tuberculosis in lungs without tuberculous lesions--an immunologic sanctuary?].
    García-García ML; Valdespino JL
    Rev Invest Clin; 2001; 53(5):460-1. PubMed ID: 11795112
    [No Abstract]   [Full Text] [Related]  

  • 19. Impaired antigen-specific CD4(+) T lymphocyte responses in cavitary tuberculosis.
    Barry S; Breen R; Lipman M; Johnson M; Janossy G
    Tuberculosis (Edinb); 2009 Jan; 89(1):48-53. PubMed ID: 18799355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.